There are no results for this module. Edit the module to change the search term used to query related articles.
“I’m not tired of living,” explains Ewert, a retired computer science professor. “I’m tired of the disease, but I’m not tired of living. And I still enjoy it enough that I’d like to continue. But the thing is that I really can’t.” FRONTLINE presents ,...
"Aestus is a key, strategic drug discovery partner in the effort to identify potential therapeutics for ALS. This collaborative effort will substantially increase our ability to identify several new existing compounds related to the information gained... Full Article at Freshnews.com
British historian Tony Judt is dying, slowly and painfully, from a variant of amyotrophic lateral sclerosis (A.L.S.), better known as Lou Gehrig’s disease. He has written matter-of-factly about his condition he is now, essentially, a quadriplegic in The... Full Article at The New York Times
March 16, 1927: Still smarting over being called “Tanglefoot* Gehrig,” Lou Gehrig insults Westbrook Pegler at spring training by calling him “Mr. Piggly-Wiggly.” *The Times says “Tanglefood,” but I assume that’s a mistake. Comments are moderated, and... Full Article at Los Angeles Times
YORK, March 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: "Amyotrophic lateral sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of... Full Article at PR Newswire
Meth labs, rodeos and Lou Gehrig's disease represent a few of the catalysts Spragg uses to tell a human story, not just a western story. And while Spragg's most recent works are fiction, he is also widely recognized for “Where Rivers Change Direction,”... Full Article at Vail Daily
Amyotrophic lateral sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
This funding is an external validation of our NICAM program awarded through a peer-reviewed process. Research shows that cyclophilin inhibitors have neuroprotective effects which open broad therapeutic areas of completely unmet medical need to Isotechnika such as stroke, Alzheimer's, Parkinson's and Lou...
This is a Lou Gehrig model first baseman's mitt
The identical immune deficits seen in mice are being looked at in humans with Parkinson's disease ... Early results are encouraging. This should pave the way for researchers to begin follow-up studies on the Parkinson's treatments and open up new opportunities to realize an immunization approach for oth...
I think he's going to listen to me now ... I think we all see. I learned a little bit from it and I think he has too. We'll have to take of ourselves a little bit. Lou Gehrig is safe. His record is safe. Don't have to worry about that.